Tiblan, Al-nashier A.

HRN: 25-77-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2024
CEFUROXIME 750MG (VIAL)
08/24/2024
08/31/2024
IV
450 Mg
Q 8 Hours
PCAP-C
Waiting Final Action 
08/27/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
08/27/2024
09/02/2024
PO
4.5mL
Q12
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: